M&A TRANSACTION · 2021
Seven Faxton-St. Luke's Dialysis Centers acquired by U.S. Renal Care, Inc.
$11.4M· 10.1x EBITDA· 0.70x revenue
Target
Seven Faxton-St. Luke's Dialysis Centers
Acquirer
U.S. Renal Care, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$15.8M
EBITDA
$1.1M
Deal Value
$11.4M
EV/EBITDA
10.1x
Context
This $11.4M acquisition of Seven Faxton-St. Luke's Dialysis Centers by U.S. Renal Care, Inc. sits in the medical practice specialty sub-vertical. The 10.1x EBITDA multiple paid in 2021 can be compared against the population median for medical practice specialty transactions of similar size on our Medical Practice Specialty valuation hub. U.S. Renal Care, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price medical practice specialty businesses on our Medical Practice Specialty strategic buyer-pool page.
Source
Data sourced from CON filings. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical practice specialty
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Seven Faxton-St. Luke's Dialysis Centers acquisition.